New prediction model for colon cancer recurrence
2021-08-31
Researchers at IGP have together with Norwegian colleagues developed a model for predicting the risk for recurrence after colon cancer surgery that is more accurate than previous models. The aim is that doctors could use the model when they discuss treatment options with their patients.
Colon cancer is on of the most common cancers in the world but improved therapy and care has in the recent decades resulted in better prognosis and survival. To assess the recurrence risk after colon cancer surgery, the doctor can use a prediction model which can also guide the decisions about adjuvant chemotherapy following the surgery.
Currently used prediction models were developed from patient material that was collected more than 10 to 20 years ago and are therefore probably not representative of the today’s care. In the present study, the researchers have created a new, updated prediction model based on data from almost 12 000 patients.
“We used data from the nationwide Swedish ColoRectal Cancer Registry and created something called a nomogram where factors such as sex, tumour classification and tumour location result in different point. The total points correspond to the predicted recurrence risk,” says Erik Osterman, doctoral student at IGP and first author of the paper.
The researchers validated the model by applying it to data from the Norwegian Colorectal Cancer Registry and found that it could predict the recurrence risk better than previous models. It performed particularly well for low-risk patient groups, which is good since it could be most beneficial in these cases.
“For patients with a low risk for disease recurrence one has to consider the risk-benefit ratio when planning potential chemotherapy after surgery. In such cases the need for an accurate prediction model is the largest. We hope that the new model can be used by doctors when they discuss treatment options with their patients,” says Erik Osterman.
The study has been published in the journal Acta Oncologica.
More information
Paper in Acta Oncologica
Erik Osterman’s research in Tobias Sjöblom’s research group
-
Y chromosome loss causes heart failure and death from cardiovascular disease
2022-07-14
Loss of the Y chromosome in blood cells of men is associated with disease and mortality, but no clear causal relationship has previously been identified. Now, researchers from IGP show in an international study in the journal Science that loss of the Y chromosome in white blood cells causes development of fibrosis in the heart, impaired heart function and death from cardiovascular diseases in men.
-
Alternative promising approach for sensitive protein detection
2022-07-08
Researchers at IGP have developed a new method to detect proteins with high specificity and sensitivity that could be use in future diagnostic analyses of patient samples.
-
Oral contraceptives and hormone treatment increase stroke risk
2022-06-27
A new study from IGP show that oral contraceptives and also hormone replacement therapy at menopause increase the risk of stroke. The increased risk was largest during the first year of treatment, after which it declined. The study, which is now published in the journal Stroke, is based on data from more than a quarter of a million women from the database UK Biobank.
-
Rare genetic variants are not the main cause of common diseases
2022-05-13
Although some rare variants can significantly increase the risk of disease for a few individuals, the majority of the genetic contribution to common diseases is due to a combination of many common genetic variants with small effects. This is shown by researchers at IGP and other departments at Uppsala University in a new comprehensive study published in the journal Nature Communications.
-
Subgroups of brain tumours associated with cell origin and disease prognosis
2022-04-25
Researchers at IGP have detected different subgroups of the brain tumour form glioblastoma, where the cancer cells’ properties depend on which cell type they originate from. The used analysis method could also separate glioblastoma patients with significant differences in survival. The findings open up for identifying specific therapeutic targets for the new subgroups of glioblastoma.
-
Armed CAR-T cells to better fight cancer
2022-04-04
Immunotherapy is increasingly becoming a successful way to treat cancer. Researchers at IGP have now developed armed CAR-T cells that reinforce the immune defence against cancer and that could increase the possibilities to successfully treat solid tumours. The study has been published in the journal Nature BioMedical Engineering.
-
Inflammation and net-like protein structures in cerebral cavernous malformations
2022-03-28
In the condition known as cavernoma, lesions arise in a cluster of blood vessels in the brain, spinal cord or retina. Researchers at IGP now show in a new study that white blood cells and protein structures associated with the immune response infiltrate the vessel lesions. The findings support that inflammation has a role in the development of cavernoma and indicate a potential biomarker for the disease.
-
Protein landscape on cancer cells mapped with new technology
2022-03-03
In recent years, great advances have been made in the development of new, successful immunotherapies to treat cancer. Two types of targeted immunotherapies that have revolutionised areas of cancer care are CAR T-cell therapy and antibody treatments. However, there are still significant challenges in the identification of cancer cell surface proteins that function as targets for immunotherapies. Mattias Belting, professor at Lund University and senior consultant at Skåne University Hospital, and guest professor at IGP, is well on the way and his group’s findings are now published in the journal PNAS.
-
CRISPR-Cas9 can generate unexpected, heritable mutations
2022-02-03
CRISPR-Cas9, the “genetic scissors”, creates new potential for curing diseases; but treatments must be reliable. In a new study, researchers have discovered that the method can give rise to unforeseen changes in DNA that can be inherited by the next generation. These scientists therefore urge caution and meticulous validation before using CRISPR-Cas9 for medical purposes.
-
New technology to study DNA in archived tissue samples
2022-01-19
Researchers at IGP have developed a technology that allows studies of DNA profiles in archived tissue samples. The technology permits investigators to better understand regulation of gene activity in cancer and precision medicine.
-
New genes associated with relapse of acute myeloid leukemia
2022-01-13
In the blood cancer type acute myeloid leukemia, it is common that patients relapse some time after treatment. Researchers from IGP have in a new study identified genes that seem to be associated with the risk of relapse. The findings may form the basis for new treatment strategies and contribute to better survival for patients with acute myeloid leukemia.